Trial · NCT03155997
Adverse events848
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
241 to 260 of 848
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nail disorder | Skin and subcutaneous tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 43 | 2,791 | 45 |
| other | Nail disorder | Skin and subcutaneous tissue disorders | Endocrine Therapy | 4 | 2,800 | 4 |
| other | Night sweats | Skin and subcutaneous tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 40 | 2,791 | 43 |
| other | Night sweats | Skin and subcutaneous tissue disorders | Endocrine Therapy | 28 | 2,800 | 31 |
| other | Onychoclasis | Skin and subcutaneous tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 46 | 2,791 | 54 |
| other | Onychoclasis | Skin and subcutaneous tissue disorders | Endocrine Therapy | 7 | 2,800 | 7 |
| other | Pruritus | Skin and subcutaneous tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 219 | 2,791 | 298 |
| other | Pruritus | Skin and subcutaneous tissue disorders | Endocrine Therapy | 110 | 2,800 | 121 |
| other | Rash | Skin and subcutaneous tissue disorders | 150 mg Abemaciclib + Endocrine Therapy | 272 | 2,791 | 332 |
| other | Rash | Skin and subcutaneous tissue disorders | Endocrine Therapy | 106 | 2,800 | 132 |
| other | Breast reconstruction | Surgical and medical procedures | 150 mg Abemaciclib + Endocrine Therapy | 28 | 2,791 | 28 |
| other | Breast reconstruction | Surgical and medical procedures | Endocrine Therapy | 22 | 2,800 | 25 |
| other | Hot flush | Vascular disorders | 150 mg Abemaciclib + Endocrine Therapy | 393 | 2,791 | 432 |
| other | Hot flush | Vascular disorders | Endocrine Therapy | 587 | 2,800 | 678 |
| other | Hypertension | Vascular disorders | 150 mg Abemaciclib + Endocrine Therapy | 101 | 2,791 | 120 |
| other | Hypertension | Vascular disorders | Endocrine Therapy | 130 | 2,800 | 158 |
| other | Hypotension | Vascular disorders | 150 mg Abemaciclib + Endocrine Therapy | 33 | 2,791 | 33 |
| other | Hypotension | Vascular disorders | Endocrine Therapy | 14 | 2,800 | 15 |
| other | Lymphoedema | Vascular disorders | 150 mg Abemaciclib + Endocrine Therapy | 282 | 2,791 | 295 |
| other | Lymphoedema | Vascular disorders | Endocrine Therapy | 207 | 2,800 | 225 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03155997/events?page=13